WAT
NYSEWaters Corporation
Website
News25/Ratings12
News · 26 weeks90-18%
2025-10-262026-04-19
Mix5490d
- Insider27(50%)
- SEC Filings10(19%)
- Other9(17%)
- Analyst4(7%)
- Earnings3(6%)
- Leadership1(2%)
Latest news
25 items- PRWaters Corporation Schedules First Quarter 2026 Earnings Conference CallMILFORD, Mass., April 20, 2026 /PRNewswire/ -- Waters Corporation (NYSE:WAT) will hold its Q1 2026 financial results conference call on Tuesday, May 5, 2026 at 8:30 a.m. Eastern Time. A live webcast of the presentation will be available on Waters Investor Relations website at https://ir.waters.com. A replay of the webcast will also be available until at least June 2, 2026, at midnight Eastern Time. About Waters CorporationWaters Corporation (NYSE:WAT) is a global leader in life sciences and diagnostics, dedicated to accelerating the benefits of pioneering science through analytical technologies, informatics, and service. With a focus on regulated, high-volume testing environments, our innova
- PRWaters Debuts Industry-First Extended-Range MALS Detector for UHPLC/UPLC, Powering Rapid Characterization of Large MoleculesDelivers up to 4x faster chromatographic run times to accelerate decisions across discovery, development, and quality workflows.1,3Achieves 10x improvement in absolute molar mass and extended sizing, without compromising resolution or analytical throughput.2Reduces sample consumption by 30-50% and solvent use by approximately 40%.3MILFORD, Mass., April 14, 2026 /CNW/ -- Waters Corporation (NYSE: WAT) today announced the launch of the Waters omniDAWN™ Multi-Angle Light Scattering (MALS) Photometer, part of the Wyatt Technology Portfolio. Featuring 18 angles of detection, the omniDAWN Photometer is the first extended-range MALS detector for Ultra High Performance Liquid Chromatography (UHPLC)
- SECSEC Form DEFA14A filed by Waters CorporationDEFA14A - WATERS CORP /DE/ (0001000697) (Filer)
- SECSEC Form DEF 14A filed by Waters CorporationDEF 14A - WATERS CORP /DE/ (0001000697) (Filer)
- PRWaters Announces FDA Clearance of the Most Comprehensive At-Home Cervical Cancer Screening Tool, the Onclarity HPV Self-Collection Kit and FDA-Approved HPV AssayFDA-approved BD Onclarity™ HPV Assay is the most comprehensive screening tool for HPV in the U.S.1,4 with extended genotyping and end-to-end automated lab workflows.At-home self-collection reduces significant barriers for unscreened or under-screened individuals who make up approximately 60% of cervical cancer cases.3Waters is establishing partnerships to enable broader nationwide access to the Onclarity™ HPV Self-Collection Kit for patients and prescribers to reduce cervical cancer risk.MILFORD, Mass., April 8, 2026 /PRNewswire/ -- Waters Corporation (NYSE:WAT) today announced that the U.S. Food and Drug Administration (FDA) has cleared the Onclarity HPV Self-Collection Kit and approved the
- INSIDERSEC Form 4 filed by Bennett Jianqing4 - WATERS CORP /DE/ (0001000697) (Issuer)
- ANALYSTWaters upgraded by Evercore ISI with a new price targetEvercore ISI upgraded Waters from In-line to Outperform and set a new price target of $350.00
- INSIDERSEC Form 4 filed by Jiang Wei4 - WATERS CORP /DE/ (0001000697) (Issuer)
- INSIDERSEC Form 4 filed by Knight Heather4 - WATERS CORP /DE/ (0001000697) (Issuer)
- SECAmendment: SEC Form SCHEDULE 13G/A filed by Waters CorporationSCHEDULE 13G/A - WATERS CORP /DE/ (0001000697) (Subject)
- SECWaters Corporation filed SEC Form 8-K: Entry into a Material Definitive Agreement8-K - WATERS CORP /DE/ (0001000697) (Filer)
- INSIDERSEC Form 4 filed by Jiang Wei4 - WATERS CORP /DE/ (0001000697) (Issuer)
- PRWaters Prices Offering of Senior NotesMILFORD, Mass., March 18, 2026 /PRNewswire/ -- Waters Corporation (NYSE:WAT) (the "Company" or "Waters") today announced that it has priced an offering (the "Offering") of $3.5 billion aggregate principal amount of the following senior notes issued by its subsidiary, Augusta SpinCo Corporation ("Augusta"): $650 million aggregate principal amount of 4.321% Senior Notes due 2027 at the issue price of 100.000% of their principal amount;$600 million aggregate principal amount of 4.398% Senior Notes due 2029 at the issue price of 100.000% of their principal amount;$750 million aggregate principal amount of 4.656% Senior Notes due 2031 at the issue price of 100.000% of their principal amount;$750
- SECSEC Form FWP filed by Waters CorporationFWP - WATERS CORP /DE/ (0001000697) (Subject)
- SECSEC Form 8-K filed by Waters Corporation8-K - WATERS CORP /DE/ (0001000697) (Filer)
- INSIDERDirector Fearon Richard H bought $306,340 worth of shares (1,000 units at $306.34), increasing direct ownership by 43% to 3,302 units (SEC Form 4)4 - WATERS CORP /DE/ (0001000697) (Issuer)
- PRWaters Flagship ARES‑G3 Rheometer Sets New Benchmark for Data Quality at Breakthrough SpeedNews Summary:Reduces standard testing times by 80%.1Delivers an industry-leading 25,000 data points per second, detecting transient material behaviors previously invisible to measurement. 2Operates with fewer calibrations and superior atmosphere and temperature control. 3SAN ANTONIO, Texas and MILFORD, Mass., March 9, 2026 /CNW/ -- Pittcon 2026 Conference + Exposition -- Waters Corporation (NYSE: WAT) today launched the ARES-G3™ Rheometer, part of the TA Instruments product line. This next-generation rheometer delivers industry-leading speed paired with best-in-class data to accelerate materials research and product development. Capturing up to 25,000 data points per second (10x more than it
- INSIDERPresident and CEO Batra Udit covered exercise/tax liability with 3,417 shares, decreasing direct ownership by 9% to 33,140 units (SEC Form 4)4 - WATERS CORP /DE/ (0001000697) (Issuer)
- INSIDERSVP & Chief Financial Officer Chaubal Amol covered exercise/tax liability with 709 shares, decreasing direct ownership by 8% to 7,796 units (SEC Form 4)4 - WATERS CORP /DE/ (0001000697) (Issuer)
- INSIDERSVP Waters Adv. Diagnostics Bennett Jianqing covered exercise/tax liability with 410 shares, decreasing direct ownership by 6% to 6,834 units (SEC Form 4)4 - WATERS CORP /DE/ (0001000697) (Issuer)
- INSIDERSVP Waters Analytical Sciences Carpio Robert L Iii was granted 997 shares, increasing direct ownership by 38% to 3,615 units (SEC Form 4)4 - WATERS CORP /DE/ (0001000697) (Issuer)
- INSIDERSVP Waters Adv. Diagnostics Bennett Jianqing was granted 986 shares, increasing direct ownership by 16% to 7,244 units (SEC Form 4)4 - WATERS CORP /DE/ (0001000697) (Issuer)
- INSIDERSVP & Chief Financial Officer Chaubal Amol was granted 1,455 shares, increasing direct ownership by 21% to 8,505 units (SEC Form 4)4 - WATERS CORP /DE/ (0001000697) (Issuer)
- INSIDERPresident and CEO Batra Udit was granted 5,165 shares, increasing direct ownership by 16% to 36,557 units (SEC Form 4)4 - WATERS CORP /DE/ (0001000697) (Issuer)
- INSIDERDirector Vergnano Mark was granted 23 shares, increasing direct ownership by 0.51% to 4,540 units (SEC Form 4)4 - WATERS CORP /DE/ (0001000697) (Issuer)